Canada · Delayed Price · Currency is CAD iFabric Earnings Call Transcripts
Fiscal Year 2025
-
Record 2025 revenue grew 20% year-over-year, with Q1 2026 guidance of CAD 25–27 million driven by expanded retail programs and proprietary brand launches. Margins are expected to recover as tariffs ease and high-margin intimate apparel resumes.
-
Q2 saw adjusted revenue growth of 5% and a record quarter, with strong inventory deposits signaling robust future sales. EBITDA margins are targeted at 10%-15%, and new clinical evidence plus regulatory progress are set to accelerate entry into healthcare and new product segments.
-
Q1 2025 saw record revenue of CAD 7.1 million, up 5% year-over-year, with strong growth in Intelligent Fabrics offsetting a decline in Intimate Apparel. Gross margin fell to 39%, and adjusted EBITDA dropped to $300,000 due to higher expenses. Management expects continued double-digit growth and is optimistic about new programs and U.S. expansion.
-
A hybrid textile technology firm reported five years of strong sales growth, driven by proprietary innovations and a focus on medical and antimicrobial applications. With robust financials, minimal debt, and global expansion plans, it is positioned for continued double-digit growth.
Fiscal Year 2024
-
Record 2024 results with revenue up 20% proportionately and Q4 up 55% year-over-year. Management expects double-digit growth in 2025, leveraging a fully owned building and expanded credit line, while mitigating U.S. tariff risks through supplier and customer negotiations.